Monday, October 3, 2022

561.316.3330

Biotechnology News Magazine

Axiom Presents “Unified Platforms: Rethinking Trial Planning and Execution” at Outsourcing in Clinical Trials UK & Ireland 2021

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Axiom Real-Time Metrics (“Axiom”), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting on June 8-9, 2021 at the Outsourcing in Clinical Trials UK & Ireland virtual event.

Over two days, delegates and industry leaders will discuss common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs and constructing defined deadlines.

On June 8, Axiom’s Heather DiFruscia, Associate Director of RTSM/IWRS and Brian Dempster, Senior Director of Global Clinical Management, will be presenting “Unified Platforms: Rethinking Trial Planning and Execution” at 2:50 PM EDT. This session will demonstrate the characteristics of traditional phased approaches for clinical trial planning and execution, highlighting new technology-driven approaches and the benefits of unified platforms.

“Instead of making the technology fit the traditional approach to trial design, powerful technology should enable a new approach to managing your trials,” Dempster says, “Unlike traditional methods that require a great amount of excel trackers and other manual work, a real-time, data-driven approach can handle ongoing data flow and allow different stakeholders of your trial to access study data instantaneously. The effectiveness of Axiom’s unified eClinical technology can offer greater visibility, accountability and awareness.”

“Unified platforms are excellent examples of continuous approaches empowered by technologies,” DiFruscia continues, “Traditionally, the phased approaches would identify risks and set triggers that use manual trackers and data reviews. But if you are applying the continuous approaches to a unified platform like Axiom’s Fusion eClinical Suite, the technology will identify trends before impact. Additionally, with all data continuously collected and monitored in a unified platform, you will also be equipped with three key solutions to yield benefits of considering technology in clinical trial execution and work, including risk management, monitoring, and eTMF.”

A live Q & A session with DiFruscia and Dempster will follow the presentation.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine